Skip to main content
Banka BioLoo Limited logo

Banka BioLoo Limited — Investor Relations & Filings

Ticker · BANKA ISIN · INE862Y01015 LEI · 9845007A5B684495YW41 National Stock Exchange of India Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 463 across all filing types
Latest filing 2023-11-14 Regulatory Filings
Country IN India
Listing National Stock Exchange of India BANKA

About Banka BioLoo Limited

https://www.bankabio.com

Banka BioLoo Limited specializes in providing sustainable sanitation solutions through the implementation of bio-digester technology. The company focuses on the design, manufacturing, and installation of bio-toilets and bio-tanks that utilize anaerobic digestion to treat human waste. This technology, originally developed by the Defence Research and Development Organisation (DRDO), converts waste into water and biogas, ensuring zero-waste discharge and environmental protection. The company serves a diverse range of sectors, including public infrastructure, railways, construction sites, and rural communities. Its service offerings extend to the operation and maintenance of sanitation facilities, as well as large-scale waste management projects. By prioritizing water conservation and hygiene, the company addresses critical sanitation challenges while promoting ecological sustainability.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure letter addressed to the National Stock Exchange of India regarding Related Party Transactions for the half year ended 30 September 2023. It references a regulatory requirement (SEBI Listing Obligations and Disclosure Requirements) and provides a specific financial period. The document length is short (1181 characters) and it is a formal disclosure rather than a full financial report. It does not contain detailed financial statements or analysis, nor is it an announcement of a report publication. This type of disclosure fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-11-14 English
Outcome of Board Meeting
Regulatory Filings
2023-11-14 English
Board Meeting — BANKA BIOLOO LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the…
Regulatory Filings
2023-11-01 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting scheduled for 14 November 2023. The key agenda includes consideration and approval of un-audited financial results for the quarter and half year ended 30 September 2023, along with the Limited Review Report. The document does not contain the financial results themselves but only announces the meeting where these results will be approved. It is a regulatory announcement pursuant to SEBI (LODR) Regulations, 2015, and is addressed to the stock exchange for dissemination. The document length is only 1508 characters, indicating it is a brief notice rather than a full financial report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain substantive financial data or the report itself.
2023-11-01 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a letter dated 31 October 2023 from Banka BioLoo Limited to the National Stock Exchange of India Limited regarding the in-principle approval for listing of equity shares allotted under the company's Employee Stock Option Plan (ESOP) 2023. It includes the approval letter from NSE granting in-principle approval subject to certain conditions and regulatory compliance. The content is an official announcement of the approval for listing shares related to ESOP, not a financial report or detailed financial data. It is a regulatory announcement about capital listing approval, specifically about share allotment under ESOP and listing approval, which fits the category of Capital/Financing Update (CAP). The document is over 5,000 characters and contains substantive information about the capital listing approval, not just a brief notification or report publication announcement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-10-31 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the submission of a certificate confirming the non-applicability of a specific regulation (Regulation 74(5) of SEBI Depositories and Participants Regulations, 2018) for the quarter ended 30 September 2023. It is a compliance-related submission and does not contain financial statements, management discussion, or detailed report content. The document length is short (1350 characters), and it is essentially a regulatory compliance certificate submission. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2023-10-09 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.